2000 characters remaining
Loading, Please Wait...
At Medicilon, we are dedicated to help our clients develop their research and discovery programs from a burst of ideas all the way to the Investigational New Drug (IND) filing phase. Our service span across medicinal chemistry, biology, API synthesis, CMC and preclinical studies. Medicilon（stock code : 688202.SH）is fully accredited by the International Laboratory Animal Assessment and Accreditation (AAALAC) and in compliance with the US FDA’s Good Laboratory Practice (GLP). The standard of laboratories is certified by the National Medical Products Administration(NMPA) for GLP compliance in China. Experimental reports present by Medicilon are valid for China and USA dual filing to facilitate the evaluation of the safety and marketing of life-changing compounds for our clients.
See what your friends are saying about Medicilon.